56 13 APPENDICES ................................................................................................................. 5 8 Appendix A: Methods for Selecting Defined Epitopes, Predicted Epitopes, and Tumor Suppressor and Driver Neoantigens ......................................................................................... 58 Appendix B: Performance Status Criteria .....................................................................